E. Langley

发表

HDAC4 deacetylase associates with and represses the MEF2 transcription factor

E. Miska, J. Pines, T. Kouzarides, 1999, The EMBO journal.

Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity

A. Lugovskoy, Xiufeng Wu, A. Sereno, 2010, The Journal of Biological Chemistry.

Drosophila immunity. A sequence homologous to mammalian interferon consensus response element enhances the activity of the diptericin promoter.

P. Georgel, E. Langley, J. Hoffmann, 1995, Nucleic acids research.

Phase I trial of daily PI3Kα inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC).

M. Berger, S. Chandarlapaty, D. Lake, 2014 .

Constitutive activation of toll-mediated antifungal defense in serpin-deficient Drosophila.

M. Ashburner, D. Gubb, E. Levashina, 1999, Science.

Low EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer

J. Ahn, M. Ahn, Keunchil Park, 2015, Oncotarget.

Post transcriptional control of the epigenetic stem cell regulator PLZF by sirtuin and HDAC deacetylases

J. Licht, T. Kouzarides, A. Zelent, 2015, Epigenetics & Chromatin.

Human SIR2 deacetylates p53 and antagonizes PML/p53‐induced cellular senescence

S. Minucci, P. Pelicci, T. Kouzarides, 2002, The EMBO journal.

MEF‐2 function is modified by a novel co‐repressor, MITR

E. Miska, T. Kouzarides, E. Langley, 1999, The EMBO journal.

A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma

D. Early, Faris M. Murad, K. Lim, 2017, Oncotarget.

A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity

Christilyn P. Graff, Xiufeng Wu, A. Sereno, 2011, mAbs.

Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response

A. Sereno, S. Demarest, E. Langley, 2010, Molecular Cancer Therapeutics.

HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2

C. Sotiriou, M. Piccart, J. Baselga, 2017, Clinical Cancer Research.

HER 2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER 2

C. Sotiriou, M. Piccart, G. Frampton, 2017 .

Decoding signaling pathways involved in prolactin-induced neuroprotection: A review

E. Langley, N. A. Rivero-Segura, M. Cerbón, 2021, Frontiers in Neuroendocrinology.

Correction: HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2

C. Sotiriou, M. Piccart, J. Baselga, 2019, Clinical Cancer Research.

Differential localization of HDAC4 orchestrates muscle differentiation.

E. Miska, J. Pines, T. Kouzarides, 2001, Nucleic acids research.

Post transcriptional control of the epigenetic stem cell regulator PLZF by sirtuin and HDAC deacetylases

J. Licht, T. Kouzarides, A. Zelent, 2015, Epigenetics & Chromatin.

Prolactin-induced neuroprotection against excitotoxicity is mediated via PI3K/AKT and GSK3β/NF-κB in primary cultures of hippocampal neurons

E. Langley, M. Cerbón, G. Molina-Salinas, 2023, Peptides.

Mechanisms of resistance to PDGFR inhibition in glioblastoma.

S. Pastorino, S. Kesari, Ying S. Chao, 2014 .